Overlay analysis of the oligonucleotide array gene expression profiles and copy number abnormalities as determined by array comparative genomic hybridization in medulloblastomas

Genes Chromosomes and Cancer

Volumn 46, Issue 1, 2007, Pages 53-66

  Lo, Ken C ^a   Rossi, Michael R ^b   Burkhardt, Tania ^a   Pomeroy, Scott L ^c   Cowell, John K ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER GENETICS; CHILD; CHILDHOOD CANCER; CHROMOSOME 10Q; CHROMOSOME 16Q; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 2P; CHROMOSOME 3Q; CHROMOSOME 6Q; CHROMOSOME 7; CHROMOSOME 8P; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; DATA ANALYSIS; DDXI GENE; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; MALE; MEDULLOBLASTOMA; MYCN GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UPREGULATION;

CEREBELLAR NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; GENE DOSAGE; GENE EXPRESSION PROFILING; HUMANS; MEDULLOBLASTOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 33751075209     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20388     Document Type: Article

References (37)

1. Avet-Loiseau H, Venuat AM, Terrier-Lacombe MJ, Lellouch-Tubiana A, Zerah M, Vassal G. 1999. Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children. Br J Cancer 79:1843-1847.
2. Bolstad BM, Irizarry RA, Astrand M, Speed TP. 2003. A comparison of normalization methods for high density oligonucleotide array-data based on variance and bias. Bioinformatics 19:185-193.
3. Brookman-Amissah N, Duchesnes C, Williamson MP, Wang Q, Ahmed A, Feneley MR, Mackay A, Freeman A, Fenwick K, Iravani M, Weber B, Ashworth A, Masters JR. 2005. Genome-wide screening for genetic changes in a matched pair of benign and prostate cancer cell lines using array CGH. Prostate Cancer Prostatic Dis 8:335-343.
4. Chen D, Xu W, Bales E, Colmenares C, Conacci-Sorrell M, Ishii S, Stavnezer E, Campisi J, Fisher DE, Ben-Ze'ev A, Medrano EE. 2003. SKI activates Wnt/β-catenin signaling in human melanoma. Cancer Res 63:6626-6634.
5. Cheng JD, Weiner LM. 2003. Tumors and their microenvironments: tilling the soil. Clin Cancer Res 9:1590-1595.
6. Commentary re: Scott, AM, Wiseman G, Welt S, Zdjei A, Lee F-T, Hopkins W, Divgi CR, Hanson LH, Mitchell P, Gansen DN, Larson SM, Ingle JN, Hoffman EW, Tanswell P, Ritter G, Cohen LS, Bette P, Arvay L, Amelsberg A, Vlock D, Rettig WJ, Old LJ. 2003. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res 9:1639-1647.
7. Cowell JK, Matsui S, Wang YD, LaDuca J, Conroy J, McQuaid D, Nowak NJ. 2004. Application of bacterial artificial chromosome array-based comparative genomic hybridization and spectral karyotyping to the analysis of glioblastoma multiforme. Cancer Genet Cytogenet 151:36-51.
8. Cowell JK, Nowak NJ. 2003. High-resolution analysis of genetic events in cancer cells using bacterial artificial chromosome arrays and comparative genome hybridization. Adv Cancer Res 90:91-125.
9. Crnogorac-Jurcevic T, Efthimiou E, Capelli P, Blaveri E, Baron A, Terris B, Jones M, Tyson K, Bassi C, Scarpa A, Lemoine NR. 2001. Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene 20:7437-7446.
10. Eberhart CG, Kratz JE, Schuster A, Goldthwaite P, Cohen KJ, Perlman EJ, Burger PC. 2002. Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol 12:36-44.
11. Eisen MB, Spellman PT, Brown PO, Botstein D. 1998. Cluster analysts and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868.
12. Fukunaga-Johnson N, Lee SW, Liebert M, Grossman HB. 1996. Molecular analysis of a gene, BB1, overexpressed in bladder and breast carcinoma. Anticancer Res 16:1085-1090.
13. Gorlin RJ. 1995. Nevoid basal cell carcinoma syndrome. Dermatol Clin 13:113-125.
14. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Toftgard R, Chenevix-Trench G, Wainwright B, Bale AE. 1996. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85:841-851.
15. Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM, Krush AJ, Berk T, Cohen Z, Tetu B, Burger PC, Wood PA, Taqi F, Booker SV, Petersen GM, Offerhaus G, Johan A, Tersmette AC, Giardiello FM, Vogelstein B, Kinzler KW. 1995. The molecular basis of Turcot's syndrome. N Engl J Med 332:839-847.
16. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW, Lee C. 2004. Detection of large-scale variation in the human genome. Nat Genet 36:949-951.
17. Johnson JH, Jr, Phillips PC. 1996. Malignant gliomas in children. Cancer Invest 14:609-621.
18. Kim SY, Lee MY, Cho KC, Choi YS, Choi JS, Sung KW, Kwon OJ, Kim HS, Kim IK, Jeong SW. 2003. Alterations in mRNA expression of ribosomal protein S9 in hydrogen peroxide-treated neurotumor cells and in rat hippocampus after transient ischemia. Neurochem Res 28:925-931.
19. Kingsley CB, Kuo WL, Polikoff D, Berchuck A, Gray JW, Jain AN. 2006. Magellan: A web based system for the integrated analysis of heterogeneous biological data and annotations; Application to DNA copy number and expression data in ovarian cancer. Cancer Informat 2:10-21.
20. Labalette C, Renard CA, Neuveut C, Buendia MA, Wei Y. 2004. Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and β-catenin. Mol Cell Biol 24:10689-10702.
21. Livan KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 25:205-210.
22. Nicholson JC, Ross FM, Kohler JA, Ellison DW. 1999. Comparative genomic hybridization and histological variation in primitive neuroectodermal tumours. Br J Cancer 80:1322-1331.
23. Nigro JM, Misra A, Zhang L, Smirnov I, Colman H, Griffin C, Ozburn N, Chen M, Pan E, Koul D, Yung WK, Feuerstein BG, Aldape KD. 2005. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res 65:1678-1686.
24. Nowak NJ, Gaile D, Conroy JM, McQuaid D, Cowell J, Carter R, Goggins MG, Hruban RH, Maitra A. 2005. Genome-wide aberrations in pancreatic adenocarcinoma. Cancer Genet Cytogenet 161:36-50.
25. Pan E, Pellarin M, Holmes E, Smirnov I1 Misra A, Eberhart CG, Burger PC, Biegel JA, Feuerstein BG. 2005. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients. Clin Cancer Res 11:4733-4740.
26. Pinkel D, Albertson DG. 2005. Array comparative genomic hybridization and its applications in cancer. Nat Genet 37 (Suppl):S11-S17.
27. Pomeroy SL, Tamayo R Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR. 2002. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436-442.
28. Quinn LM, Johnson BV, Nicholl J, Sutherland GR, Kalionis B. 1997. Isolation and identification of homeobox genes from the human placenta including a novel member of the Distal-less family, DLX4. Gene 187:55-61.
29. Ramirez-Montagut T, Blachere NE, Sviderskaya EV, Bennett DC, Rettig WJ, Garin-Chesa P, Houghton AN. 2004. FAPα, a surface peptidase expressed during wound healing, is a tumor suppressor. Oncogene 23:5435-5446.
30. Rossi MR, Conroy J, McQuaid D, Nowak NJ, Rutka JT, Cowell JK. 2006. Array CGH analysis of pediatrice medulloblastomas. Genes Chromosomes Cancer 45:290-303.
31. Rossi MR, La Duca J, Matsui S, Nowak NJ, Hawthorn L, Cowell JK. 2005. Novel amplicons on the short arm of chromosome 7 identified using high resolution array CGH contain over expressed genes in addition to EGFR in glioblastoma multiforme. Genes Chromosomes Cancer 44:392-404.
32. Russo C, Pellarin M, Tingby O, Bollen AW, Lamborn KR, Mohapatra G, Collins VP, Feuerstein BG. 1999. Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors. Cancer 86:331-339.
33. Schutz BR, Scheurlen W, Krauss J, du Manoir S, Joos S, Bentz M, Lichter P. 1996. Mapping of chromosomal gains and losses in primitive neuroectodermal tumors by comparative genomic hybridization. Genes Chromosomes Cancer 16:196-203.
34. Turcot J, Despres JP, St Pierre F. 1959. Malignant tumors of the central nervous system associated with familial polyposis of the colon: Report of two cases. Dis Colon Rectum 2:465-468.
35. Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121.
36. Varma G, Varma R, Huang H, Pryshchepava A, Groth J, Fleming D, Nowak NJ, McQuaid D, Conroy J, Mahoney M, Moysich K, Falkner KL, Geradts J. 2005. Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York. Br J Cancer 93:699-708.
37. Zakrzewska M, Rieske P, Debiec-Rychter M, Zakrzewski K, Polis L, Fiks T, Liberski PP. 2004. Molecular abnormalities in pediatric embryonal brain tumors-analysis of loss of heterozygosity on chromosomes 1, 5, 9, 10, 11, 16, 17 and 22. Clin Neuropathol 23:209-217.